Patents

 

New molecules against superbugs
Bacterial resistance and the consequences of superbugs’ infections during hospitalization are one of the major concern of the new millennium.
Dr. Andrea Pace’s research group, in collaboration with Dr. Cosimo Gianluca Fortuna (Università di Catania) and Dr. Rosario Musumeci (Università di Milano Bicocca) has developed a series of oxazolidinone compounds of general formula (I) which possess antibiotic activity against multidrug resistant Gram positive pathogens, including bacteria resistant to linezolid, one of the “last defense” antibiotics in clinical use.

formula1

This series of compounds, which has been submitted for patenting, presents lower than linezolid toxicity, thus offering an ideal profile for further clinical/therapeutic development. The research group is currently looking for sponsors to finance the second phase of experiments and the international extension of IPR.

For more information

5x1000

5x1000

Job opportunities

News

Lo I.E.ME.S.T. presenta il GR.IN. Cluster al Green Conservation of Cultural Hertitage
L' Istituto I.E.ME.S.T. ha collaborato all'organizzazione della Terza Conferenza Internazionale  "Green Conservation of Cultural Heritage", dove 250 ricercatori provenienti da 19 Paesi si sono confrontati sulle tematiche dello sviluppo sostenibile.In particolare la delegazione del Dipartimento NIMA (NanoInnovative Materials), ha presentato il Cluster GR.IN. ottenendo entusiastica adesione da parte di numerosi Partner Europei.

BANDO PER LA SELEZIONE
DI IDEE E PROGETTI
INNOVATIVI
CALL FOR PROPOSALS
“WORKING INTELLIGENCE,
SPREADING KNOWLEDGE”

 


 

Subscribe to Newsletter

Social Networks

WebMail

Privacy

Privacy